Dapagliflozin Beyond Glucose Lowering: Mechanisms of Renal and Systemic Protection
Madison L. Wise, Abdel A. Alli · 2026
Read Dapagliflozin Beyond Glucose Lowering: Mechanisms of Renal and Systemic Protection by Madison L. Wise, Abdel A. Alli (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13610267.txt.
Description
Madison Wise and Abdel Alli review how a diabetes pill protects kidneys and the wider body beyond sugar control in a 2026 paper. Dapagliflozin began as a way to spill glucose in urine. Trials then showed slower kidney decline and fewer heart failures, even without diabetes.
The review walks from the drugs plant-derived ancestor to modern selective versions. Inside kidney tubules it retunes several sodium and phosphate handlers at once. It also damps inflammation and scarring signals, steadies cell power plants, and eases stress responses. The authors frame the pill as a system drug, not a sugar drug.
Catalog record
| CREATOR | Madison L. Wise, Abdel A. Alli |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |